Coronavirus - Drugs & Diseases

 
 
  • Trending Clinical Topic: Antibodies News about vaccine efficacy and the potential for an antibody drug to prevent COVID-19 progression in high-risk patients resulted in this week's top trending clinical topic.
  • Fast Five Quiz: Statins Statins are cholesterol-lowering agents and are among the most commonly prescribed drugs. Are you familiar with key clinical concerns and recommendations for their use? Take this short quiz.
  • Trending Clinical Topic: Shift Work Recent studies linking adverse health conditions, including COVID-19, to shift work resulted in this week's top trending clinical topic.
  • Trending Clinical Topic: P.1 Coronavirus Variant New details about the transmissibility and antibody response of the P.1 coronavirus variant first identified in Brazil resulted in this week's top trending clinical topic.
  • Trending Clinical Topic: COVID Antibody Cocktail Details about phase 3 data regarding protection against COVID-19 conferred by Regeneron's monoclonal antibody cocktail led to this week's top trending clinical topic.
  • Trending Clinical Topic: Pandemic Periods Surveys suggesting that the pandemic has had a drastic effect on menstrual cycles, as well as news about other gynecologic and urologic concerns, resulted in this week's top trending clinical topic.
  • Trending Clinical Topic: Saliva New research into COVID transmission and disease development, as well as a potential game-changing test for sports-related concussions, made saliva this week's top trending clinical topic.
  • Trending Clinical Topic: Thyroid and COVID-19 A study revealing an association between subacute thyroiditis and COVID-19, as well as new findings regarding thyroid testing and treatments, resulted in this week's top trending clinical topic.
  • COVID-19 Guidance for Surgeons
  • Trending Clinical Topic: Obesity and COVID Further insight into the relationship between obesity and COVID-19, including concerns about antibody response to vaccination, resulted in this week's top trending clinical topic.
  • Fast Five Quiz: Electrolyte Disorders Electrolyte disorders can cause significant harm. From hyponatremia to hyperkalemia, take this quick quiz and make sure you're prepared to recognize and treat the most common electrolyte disturbances.
  • Trending Clinical Topic: COVID Treatments Although the focus has largely been on vaccinations and COVID-19 prevention, recent studies and guidance regarding potential treatments have become this week's top trending clinical topic.
  • Fast Five Quiz: COVID-Related Conditions Among those who have recovered from acute COVID-19, ongoing symptoms have been reported. Do you know key aspects of conditions related to coronavirus infection? Test yourself with this short quiz.
  • Trending Clinical Topic: PASC As questions about the condition continue, a new acronym for what has been called "long COVID" was recently introduced and is this week's top trending clinical topic.
  • Trending Clinical Topic: Single-Dose Vaccination Data about the efficacy of a single dose of Pfizer and Moderna vaccines, as well as key information about the Johnson & Johnson vaccine, resulted in this week's trending clinical topic.
  • Fast Five Quiz: Probiotics Facts vs Fiction Misperceptions about probiotics are common, but key information can help you advise patients on their use. Can you separate fact from fiction regarding probiotics? Take this short quiz.
  • Blackout at Rest and Slurring in a Man Afraid of COVID-19 A 62-year-old has had palpitations at rest, accompanied by dizziness and a blackout. He attributed the episodes to stress from the COVID-19 pandemic and had not sought medical attention. What's wrong?
  • Trending Clinical Topic: COVID Brain Fog Discovery of a possible key to a long-term COVID concern, the development of new guidelines, and the creation of a neurologic symptom database resulted in this week's top trending clinical topic.
  • FDA Approvals, Highlights, and Summaries: Hospitalists Stay Current on new FDA Drug Approvals.
  • FDA Approvals, Highlights, and Summaries: Infectious Disease Stay Current on new FDA Drug Approvals.